Tumour-microenvironment interaction: the effect of analgesics. (#145)
4:40 PM
The inflammation-resolving trihydroxy-docosahexaenoic acid derivative, resolvin D2 is an estrogen receptor ligand that supports MCF-7 cell proliferation (#146)
4:40 PM
The inflammatory cytokine oncostatin M is a potent inducer of mammary tumor metastasis (#147)
4:40 PM
Enhanced expression of MDA-9/syntenin induced through the tissue-factor pathway in melanoma promotes tumor cell migration and metastasis (#148)
4:40 PM
The contribution of stromal caveolin-1 to breast cancer metastasis (#149)
4:40 PM
Suppression of breast cancer metastasis by BMP4 (#150)
4:40 PM
Stanniocalcin 1 in mammary tumorigenesis (#151)
4:40 PM
Melaleuca alternifolia Concentrate (MAC): a novel plant-derived anticancer agent (#152)
4:40 PM
Tetraspanins as metastatic regulators of prostate cancer (#153)
4:40 PM
Microenvironmental regulation of kinase signalling dynamics as a critical mediator of tumour metastasis (#154)
4:40 PM
CD151, a novel candidate for regulation of prostate cancer cell motility, invasion and angiogenesis (#155)
4:40 PM
Metastasis in the ovarian cancer microenvironment is induced by kallikrein proteases (#156)
4:40 PM
Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice (#157)
4:40 PM
Loss of osteoclasts contributes to the development of osteosarcoma pulmonary metastasis (#158)
4:40 PM
Glucocorticoids inhibit breast tumour cell migration (#159)
4:40 PM
Endogenous interleukin-4 receptor expression confers a distinct survival advantage to mammary and colon tumor cells in vitro and in vivo. (#160)
4:40 PM
The activity of the urokinase receptor in promoting tumor growth requires its interaction with the extracellular matrix protein vitronectin (#161)
4:40 PM
Surfactant protein A suppresses progression of human lung adenocarcinoma in an experimental lung metastasis model. (#162)
4:40 PM
The heparan sulfate mimetic PG545 acts against heparanase to reduce metastasis and prolong survival in 4T1 breast carcinoma model (#163)
4:40 PM
Potential involvement of ASC in cancer progression and metastasis. (#164)
4:40 PM
Cathepsin D is required for tumour stroma development. (#165)
4:40 PM
Anti-adhesive and anti-apoptotic effect of epiglycanin/mucin 21 (#166)
4:40 PM
Galectin-1 as a Potent Target for Cancer and Metastasis Therapy: Role in the Tumour Microenvironment (#167)
4:40 PM
Analysis of the role of the G protein-coupled receptors formyl peptide receptor-1, -2, and -3 in progression of human and murine breast cancer (#168)
4:40 PM
Three-dimensional (3D) modelling of the prostate cancer microenvironment (#169)
4:40 PM
NBRI16716A inhibits tumor growth through modulating tumor-stromal cell interactions (#170)
4:40 PM
Expression profiling of ECM proteins in Indian Patients with Urothelial carcinoma of bladder (#171)
4:40 PM
Testing the efficacy of novel HDAC inhibitors for the treatment of breast cancer brain metastasis (#172)
4:40 PM
3,3-diindolylmethane plus LY294002 suppress the oncogenic activity of YAP in colon carcinoma cancer cells (#173)
4:40 PM
Overxpression of Angiomodulin (AGM/IGFBP-rP1) in Tumor Stroma and Vasculature: Differential Regulation and Functions. (#174)
4:40 PM
Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through down-regulation of NF-kappa-B activity (#175)
4:40 PM
Annexin A2 released during ovarian cancer-peritoneal cell interaction promotes a pro-metastatic cancer cell behaviour (#176)
4:40 PM
Resistance to anoikis alters the adhesion and promotes the increase of syndecan-4 and heparanase expression in endothelial cells in culture. (#177)
4:40 PM
Host-derived CCL2 plays a critical role in prostate cancer growth and skeletal metastasis (#178)
4:40 PM
Investigating the anti-metastatic activity of the recombinant disintegrin domain of ADAM9 in breast cancer cell lines (#179)
4:40 PM
A role for the disintegrin domain of adam9 in tumor cell transmigration and cell adhesion (#180)
4:40 PM
Alteration of tumor microenvironment during antiangiogenic therapy in colorectal cancer xenograft. (#181)
4:40 PM
SSeCKS modulates metastasis through multiple organ- and route-specific tumor-microenvironment interactions. (#182)
4:40 PM
N-glycosylation regulates cathepsin L2 functions (#183)
4:40 PM
Characterization of malignant melanoma growth triggered by the brain microenvironment in experimental metastasis models (#184)
4:40 PM
Drug Transporters are Differentially Expressed in Cancer-Associated Pancreatic Stellate Cells (Key Cells Involved in Enhancing Pancreatic Cancer Progression and Chemoresistance). (#185)
4:40 PM
Sympathetic nervous system regulation of tumor associated macrophages in metastasis (#186)
4:40 PM
Targeting CSF-1 induced macrophage migration to inhibit tumour invasion and metastasis (#187)
4:40 PM
Is β3 integrin a good therapeutic target for bone-metastatic breast tumours? (#188)
4:40 PM
The microenvironment factor S100A4 as a modulator of tumor-stroma crosstalk and aggressive phenotype in malignant melanoma (#189)
4:40 PM
Type 1 interferons as potent suppressors of breast cancer metastasis to bone (#190)
4:40 PM
Laminin Gamma2 Chain Promotes Invasion of Tumor Cells into Vascular Endothelial Cell Layer In Vitro (#191)
4:40 PM
The tumour-stroma microenvironment of late stage ovarian cancer in 3D (#192)
4:40 PM
Paracrine Hedgehog signaling: Roles in tumor microenvironment and metastasis (#193)
4:40 PM
Immune regulation of breast cancer metastasis (#194)
4:40 PM
Degradation products of hyaluronan produced in the context of tumors are novel regulators of lymphangiogenesis (#195)
4:40 PM
Critical roles of Notch signaling pathway in colon cancer metastasis (#196)
4:40 PM
TGFBR3 blocks human ovarian cancer spheroid adhesion and invasion in a three-dimensional culture model of intraperitoneal metastasis (#197)
4:40 PM
Metastatic tumours promote monocyte mobilisation (#198)
4:40 PM
Aloe vera and honey solution and ethanolic fraction decrease metastatic process in Walker 256 tumour-bearing rats. (#199)
4:40 PM
The antimicrobial peptide LL-37 inhibits migration of the prostate cancer PC-3 and DU145 cell lines (#200)
4:40 PM
Anti-tumor effect of VEGF-targeted therapy on Synovial sarcoma (#201)
4:40 PM
Targeting L-type amino acid transporter 1 (LAT1) to suppress metastasis in prostate cancer (#202)
4:40 PM
Phospholipase A2 activities in cancers (#203)
4:40 PM
Hepatocyte Growth Factor: A potential therapeutic target in pancreatic cancer (#204)
4:40 PM
Osteopontin promotes lung cancer invasion and metastasis by improve the invadopodia formation (#205)
4:40 PM
Local release of Osteoprotegerin by breast cancer cells inhibits cancer-induced osteolysis and intra-osseous tumour burden but promotes pulmonary metastasis. (#206)
4:40 PM